# Fastly, Inc.: financial statements, quarterly

FSLY · Nasdaq · CIK 1517413 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsly.md) · [Financials](/companies/fsly/financials.md) · [Filings](/companies/fsly/filings.md) · [Insiders](/companies/fsly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [128](/filings/0001517413-24-000216.md) | [138 d](/filings/0001517413-26-000053.md) | [134](/filings/0001517413-25-000111.md) | [132](/filings/0001517413-25-000218.md) | [137](/filings/0001517413-25-000299.md) | [141 d](/filings/0001517413-26-000053.md) | [144](/filings/0001517413-26-000132.md) | [149](/filings/0001517413-26-000213.md) | [158](/filings/0001517413-25-000299.md) | [173 d](/filings/0001517413-26-000053.md) | [173](/filings/0001517413-26-000132.md) | [183](/filings/0001517413-26-000213.md) |
| Cost of revenue | $m | [61.7](/filings/0001517413-24-000216.md) | [62.0 d](/filings/0001517413-26-000053.md) | [60.3](/filings/0001517413-25-000111.md) | [59.5](/filings/0001517413-25-000218.md) | [62.5](/filings/0001517413-25-000299.md) | [65.5 d](/filings/0001517413-26-000053.md) | [67.7](/filings/0001517413-26-000132.md) | [67.6](/filings/0001517413-26-000213.md) | [65.9](/filings/0001517413-25-000299.md) | [66.7 d](/filings/0001517413-26-000053.md) | [64.8](/filings/0001517413-26-000132.md) | [67.4](/filings/0001517413-26-000213.md) |
| Gross profit | $m | [66.1](/filings/0001517413-24-000216.md) | [75.8 d](/filings/0001517413-26-000053.md) | [73.2](/filings/0001517413-25-000111.md) | [72.9](/filings/0001517413-25-000218.md) | [74.7](/filings/0001517413-25-000299.md) | [75.1 d](/filings/0001517413-26-000053.md) | [76.8](/filings/0001517413-26-000132.md) | [81.1](/filings/0001517413-26-000213.md) | [92.3](/filings/0001517413-25-000299.md) | [106 d](/filings/0001517413-26-000053.md) | [108](/filings/0001517413-26-000132.md) | [116](/filings/0001517413-26-000213.md) |
| Research and development | $m | [39.1](/filings/0001517413-24-000216.md) | [38.3 d](/filings/0001517413-26-000053.md) | [38.2](/filings/0001517413-25-000111.md) | [35.1](/filings/0001517413-25-000218.md) | [31.9](/filings/0001517413-25-000299.md) | [32.7 d](/filings/0001517413-26-000053.md) | [37.4](/filings/0001517413-26-000132.md) | [42.2](/filings/0001517413-26-000213.md) | [41.4](/filings/0001517413-25-000299.md) | [41.6 d](/filings/0001517413-26-000053.md) | [42.0](/filings/0001517413-26-000132.md) | [42.1](/filings/0001517413-26-000213.md) |
| Operating income | $m | [(58.3)](/filings/0001517413-24-000216.md) | [(42.6) d](/filings/0001517413-26-000053.md) | [(46.3)](/filings/0001517413-25-000111.md) | [(46.7)](/filings/0001517413-25-000218.md) | [(40.6)](/filings/0001517413-25-000299.md) | [(34.3) d](/filings/0001517413-26-000053.md) | [(38.2)](/filings/0001517413-26-000132.md) | [(36.9)](/filings/0001517413-26-000213.md) | [(28.8)](/filings/0001517413-25-000299.md) | [(15.1) d](/filings/0001517413-26-000053.md) | [(23.9)](/filings/0001517413-26-000132.md) | [(14.4)](/filings/0001517413-26-000213.md) |
| Interest expense | $m | [0.9](/filings/0001517413-23-000303.md) | [0.7 d](/filings/0001517413-24-000048.md) | [0.6](/filings/0001517413-24-000104.md) | [0.5](/filings/0001517413-25-000218.md) | [0.5](/filings/0001517413-25-000299.md) | [1.2 d](/filings/0001517413-26-000053.md) | [3.2](/filings/0001517413-26-000132.md) | [3.2](/filings/0001517413-26-000213.md) | [3.2](/filings/0001517413-25-000299.md) | [3.2 d](/filings/0001517413-26-000053.md) | [3.3](/filings/0001517413-26-000132.md) | [3.3](/filings/0001517413-26-000213.md) |
| Income tax | $m | [(0.0)](/filings/0001517413-24-000216.md) | [(0.5) d](/filings/0001517413-26-000053.md) | [0.3](/filings/0001517413-25-000111.md) | [0.7](/filings/0001517413-25-000218.md) | [0.5](/filings/0001517413-25-000299.md) | [1.1 d](/filings/0001517413-26-000053.md) | [0.7](/filings/0001517413-26-000132.md) | [0.6](/filings/0001517413-26-000213.md) | [0.6](/filings/0001517413-25-000299.md) | [0.7 d](/filings/0001517413-26-000053.md) | [(4.1)](/filings/0001517413-26-000132.md) | [0.3](/filings/0001517413-26-000213.md) |
| Net income | $m | [(54.3)](/filings/0001517413-24-000216.md) | [(23.4) d](/filings/0001517413-26-000053.md) | [(43.4)](/filings/0001517413-25-000111.md) | [(43.7)](/filings/0001517413-25-000218.md) | [(38.0)](/filings/0001517413-25-000299.md) | [(32.9) d](/filings/0001517413-26-000053.md) | [(39.1)](/filings/0001517413-26-000132.md) | [(37.5)](/filings/0001517413-26-000213.md) | [(29.5)](/filings/0001517413-25-000299.md) | [(15.5) d](/filings/0001517413-26-000053.md) | [(20.5)](/filings/0001517413-26-000132.md) | [(15.6)](/filings/0001517413-26-000213.md) |
| Diluted EPS | $ per share | [(0.42)](/filings/0001517413-24-000216.md) | not reported | [(0.32)](/filings/0001517413-25-000111.md) | [(0.32)](/filings/0001517413-25-000218.md) | [(0.27)](/filings/0001517413-25-000299.md) | not reported | [(0.27)](/filings/0001517413-26-000132.md) | [(0.26)](/filings/0001517413-26-000213.md) | [(0.20)](/filings/0001517413-25-000299.md) | not reported | [(0.13)](/filings/0001517413-26-000132.md) | [(0.10)](/filings/0001517413-26-000213.md) |
| Basic EPS | $ per share | [(0.42)](/filings/0001517413-24-000216.md) | not reported | [(0.32)](/filings/0001517413-25-000111.md) | [(0.32)](/filings/0001517413-25-000218.md) | [(0.27)](/filings/0001517413-25-000299.md) | not reported | [(0.27)](/filings/0001517413-26-000132.md) | [(0.26)](/filings/0001517413-26-000213.md) | [(0.20)](/filings/0001517413-25-000299.md) | not reported | [(0.13)](/filings/0001517413-26-000132.md) | [(0.10)](/filings/0001517413-26-000213.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [270](/filings/0001517413-24-000216.md) | [108](/filings/0001517413-26-000053.md) | [151](/filings/0001517413-25-000111.md) | [147](/filings/0001517413-24-000175.md) | [218](/filings/0001517413-24-000216.md) | [286](/filings/0001517413-26-000053.md) | [125](/filings/0001517413-25-000111.md) | [82.5](/filings/0001517413-25-000218.md) | [113](/filings/0001517413-25-000299.md) | [181](/filings/0001517413-26-000213.md) | [147](/filings/0001517413-26-000132.md) | [89.8](/filings/0001517413-26-000213.md) |
| Current assets | $m | [551](/filings/0001517413-23-000303.md) | [464](/filings/0001517413-25-000063.md) | [460](/filings/0001517413-24-000104.md) | [451](/filings/0001517413-24-000175.md) | [453](/filings/0001517413-24-000216.md) | [440](/filings/0001517413-26-000053.md) | [453](/filings/0001517413-25-000111.md) | [465](/filings/0001517413-25-000218.md) | [480](/filings/0001517413-25-000299.md) | [507](/filings/0001517413-26-000213.md) | [490](/filings/0001517413-26-000132.md) | [479](/filings/0001517413-26-000213.md) |
| Total assets | $m | [1,641](/filings/0001517413-23-000303.md) | [1,525](/filings/0001517413-25-000063.md) | [1,506](/filings/0001517413-24-000104.md) | [1,483](/filings/0001517413-24-000175.md) | [1,472](/filings/0001517413-24-000216.md) | [1,451](/filings/0001517413-26-000053.md) | [1,449](/filings/0001517413-25-000111.md) | [1,463](/filings/0001517413-25-000218.md) | [1,471](/filings/0001517413-25-000299.md) | [1,499](/filings/0001517413-26-000213.md) | [1,514](/filings/0001517413-26-000132.md) | [1,504](/filings/0001517413-26-000213.md) |
| Current liabilities | $m | [143](/filings/0001517413-23-000303.md) | [148](/filings/0001517413-25-000063.md) | [120](/filings/0001517413-24-000104.md) | [109](/filings/0001517413-24-000175.md) | [114](/filings/0001517413-24-000216.md) | [104](/filings/0001517413-26-000053.md) | [301](/filings/0001517413-25-000111.md) | [313](/filings/0001517413-25-000218.md) | [329](/filings/0001517413-25-000299.md) | [194](/filings/0001517413-26-000213.md) | [163](/filings/0001517413-26-000132.md) | [143](/filings/0001517413-26-000213.md) |
| Total liabilities | $m | [672](/filings/0001517413-23-000303.md) | [546](/filings/0001517413-25-000063.md) | [514](/filings/0001517413-24-000104.md) | [501](/filings/0001517413-24-000175.md) | [502](/filings/0001517413-24-000216.md) | [486](/filings/0001517413-26-000053.md) | [492](/filings/0001517413-25-000111.md) | [521](/filings/0001517413-25-000218.md) | [534](/filings/0001517413-25-000299.md) | [570](/filings/0001517413-26-000213.md) | [536](/filings/0001517413-26-000132.md) | [513](/filings/0001517413-26-000213.md) |
| Long-term debt | $m | [473](/filings/0001517413-23-000303.md) | [344](/filings/0001517413-25-000063.md) | [344](/filings/0001517413-24-000104.md) | [344](/filings/0001517413-24-000175.md) | [344](/filings/0001517413-24-000216.md) | [338](/filings/0001517413-26-000053.md) | [150](/filings/0001517413-25-000111.md) | [150](/filings/0001517413-25-000218.md) | [150](/filings/0001517413-25-000299.md) | [323](/filings/0001517413-26-000213.md) | [324](/filings/0001517413-26-000132.md) | [324](/filings/0001517413-26-000213.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001517413-26-000053.md) | [188](/filings/0001517413-25-000111.md) | [188](/filings/0001517413-25-000218.md) | [188](/filings/0001517413-25-000299.md) | [38.6](/filings/0001517413-26-000213.md) | [0.0](/filings/0001517413-26-000132.md) | [0.0](/filings/0001517413-26-000213.md) |
| Shareholders' equity | $m | [969](/filings/0001517413-24-000216.md) | [979](/filings/0001517413-26-000053.md) | [992](/filings/0001517413-25-000218.md) | [981](/filings/0001517413-25-000299.md) | [969](/filings/0001517413-25-000299.md) | [965](/filings/0001517413-26-000213.md) | [957](/filings/0001517413-26-000213.md) | [943](/filings/0001517413-26-000213.md) | [937](/filings/0001517413-25-000299.md) | [930](/filings/0001517413-26-000213.md) | [977](/filings/0001517413-26-000213.md) | [991](/filings/0001517413-26-000213.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.4) d](/filings/0001517413-24-000216.md) | [(7.4) d](/filings/0001517413-26-000053.md) | [11.1](/filings/0001517413-25-000111.md) | [(4.9) d](/filings/0001517413-25-000218.md) | [5.0 d](/filings/0001517413-25-000299.md) | [5.2 d](/filings/0001517413-26-000053.md) | [17.3](/filings/0001517413-26-000132.md) | [25.8 d](/filings/0001517413-26-000213.md) | [28.9 d](/filings/0001517413-25-000299.md) | [22.4 d](/filings/0001517413-26-000053.md) | [28.9](/filings/0001517413-26-000132.md) | [39.3 d](/filings/0001517413-26-000213.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001517413-24-000216.md) | [2.7 d](/filings/0001517413-26-000053.md) | [1.6](/filings/0001517413-25-000111.md) | [1.8 d](/filings/0001517413-25-000218.md) | [2.0 d](/filings/0001517413-25-000299.md) | [5.0 d](/filings/0001517413-26-000053.md) | [2.6](/filings/0001517413-26-000132.md) | [9.9 d](/filings/0001517413-26-000213.md) | [6.0 d](/filings/0001517413-25-000299.md) | [10.2 d](/filings/0001517413-26-000053.md) | [21.0](/filings/0001517413-26-000132.md) | [31.6 d](/filings/0001517413-26-000213.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [122](/filings/0001517413-23-000303.md) | [125](/filings/0001517413-24-000104.md) | [128](/filings/0001517413-24-000175.md) | [130](/filings/0001517413-24-000216.md) | [135](/filings/0001517413-25-000111.md) | [137](/filings/0001517413-25-000218.md) | [139](/filings/0001517413-25-000299.md) | [143](/filings/0001517413-26-000132.md) | [146](/filings/0001517413-26-000213.md) | [148](/filings/0001517413-25-000299.md) | [154](/filings/0001517413-26-000132.md) | [158](/filings/0001517413-26-000213.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 159,300,000 at 2026-07-24, from the cover of the [10-Q filed 2026-08-05](/filings/0001517413-26-000213.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.